The combination of nivolumab, gemcitabine and cisplatin produces significant pathologic response rates in patients with muscle-invasive bladder cancer (MIBC) in the neoadjuvant setting, according to new data from the phase II Bladder Cancer Signal Seeking Trial.
Breast cancer patients’ use of certain dietary supplements before and during chemotherapy is linked to an increased risk of disease recurrence and death, a recent study involving Cleveland Clinic researchers has found.
When cancer radiation therapy does collateral damage to the heart, patients pose latent clinical challenges that demand a true center of excellence.
Historically, the use of upfront chemotherapy in advanced prostate cancer has faced significant challenges. But recent research results showing that systemic chemotherapy improves overall survival in patients with metastatic castration-resistant prostate cancer have changed the thinking about its use.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Many chemotherapy agents are cardiotoxic, making the treatment of cancer and heart disease a challenge. Our cardio-oncologist provides advice on how to minimize heart damage during cancer treatment.
The nursing team in the Infusion Center at Medina Hospital, a Cleveland Clinic community hospital, has started a support program that has improved patient compliance and team spirit.
Hyperthermic intraperitoneal chemotherapy, which involves the intraoperative delivery and circulation of heated cancer drugs, is showing promise for cancers of the peritoneal cavity arising from gynecologic cancers. The technique is a welcome development in the treatment of a disease whose outcome has changed little in the past two decades.